Renalytix plc Quarterly Deferred Tax Assets, Net of Valuation Allowance in USD from Q2 2018 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Renalytix plc quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q2 2018 to Q2 2023.
  • Renalytix plc Deferred Tax Assets, Net of Valuation Allowance for the quarter ending June 30, 2023 was $453K, a 21.6% decline year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $453K -$125K -21.6% Jun 30, 2023 10-K 2023-09-28
Q2 2022 $578K -$1.5M -72.2% Jun 30, 2022 10-K 2023-09-28
Q2 2021 $2.08M +$1.95M +1485% Jun 30, 2021 20-F 2022-10-31
Q2 2020 $131K +$73K +126% Jun 30, 2020 20-F 2022-10-31
Q2 2019 $58K +$58K Jun 30, 2019 20-F/A 2022-08-01
Q2 2018 $0 Jun 30, 2018 20-F/A 2020-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.